Emily Rychak

CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL.

M. Trotter, C. Fontanillo, A. Klippel, 2015, Blood.

Structure of the human Cereblon–DDB1–lenalidomide complex reveals basis for responsiveness to thalidomide analogs

H. Handa, Y. Hirano, T. Hakoshima, 2014, Nature Structural &Molecular Biology.

Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide

S. Karasawa, H. Handa, A. Lopez-Girona, 2012, Leukemia.